Study of TBI-1501 for Relapsed or Refractory Acute Lymphoblastic Leukemia
Study of TBI-1501 for Relapsed or Refractory Acute Lymphoblastic Leukemia
Active, not recruiting · NCT03155191 · Registry updated 2024-11-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of TBI-1501 for Relapsed or Refractory Acute Lymphoblastic Leukemia | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms, Experimental, Precursor Cell Lymphoblastic Leukemia-Lymphoma, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Active, not recruiting | Phase 1 / Phase 2 | 2024-11-20 | NCT03155191 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Takara Bio Inc. | 5 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Akita University Hospital | Akita | Japan | 3 |
| Cancer Institute Hospital Of JFCR | Kōto | Japan | 1 |
| Hokkaido University Hospital | Sapporo | Japan | 59 |
| Jichi Medical University Hospital | Shimotsuke-Shi | Japan | 7 |
| Kobe City Medical Center General Hospital | Kobe | Japan | 25 |
| Kyushu University Hospital | Higashiku | Japan | 2 |
| Mie University Hospital | Tsu | Japan | 18 |
| Okayama University Hospital | Okayama | Japan | 20 |
| The Institute of Medical Science, The University of Tokyo | Minato-ku | Japan | 2 |
| Tohoku University Hospital | Sendai | Japan | 55 |
| University of Fukui Hospital | Yoshida | Japan | 3 |